Rick E Winningham Insider Trading
Get free email notifications about insider trading for Rick E Winningham.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rick E Winningham. Rick E Winningham is an Chief Executive Officer in Innoviva, Inc. ($THRX) and a Director in Jazz Pharmaceuticals plc ($JAZZ) and a Director in OncoMed Pharmaceuticals Inc ($OMED) and an Chief Executive Officer in Theravance Biopharma, Inc. ($TBPH).
Address: THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO 94080 CA
Companies in which Rick E Winningham is an Insider
Innoviva, Inc.
Trading Symbol: THRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rick E Winningham: Chief Executive Officer
Holdings: 859,238 shares
Latest Transaction: Jun 04 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jazz Pharmaceuticals plc
Trading Symbol: JAZZIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rick E Winningham: Director
Holdings: 7,129 shares
Current Value: $891,481
Latest Transaction: Aug 10 2020
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OncoMed Pharmaceuticals Inc
Trading Symbol: OMEDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rick E Winningham: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 25 2018
$OMED Market Capitalization: $294.51M
$OMED Previous Close: $8.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Theravance Biopharma, Inc.
Trading Symbol: TBPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rick E Winningham: Chief Executive Officer
Holdings: 1,445,169 shares
Current Value: $44,222,171
Latest Transaction: Feb 10 2021
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Rick E Winningham
Sentiment: All, THRX, JAZZ, OMED, TBPH
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 10 2021 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 170,000 | 0 | 1,445,169 | 1.3 M to 1.4 M (+13.33 %) |
Aug 24 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 18.22 | 13,946 | 254,096 | 1,289,115 | 1.3 M to 1.3 M (-1.07 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 125.87 | 931 | 117,185 | 6,198 | 7.1 K to 6.2 K (-13.06 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 2,705 | 0 | 7,129 | 4.4 K to 7.1 K (+61.14 %) |
May 22 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 26.67 | 13,946 | 371,940 | 1,303,061 | 1.3 M to 1.3 M (-1.06 %) |
Feb 24 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 25.90 | 96,850 | 2,508,415 | 1,315,605 | 1.4 M to 1.3 M (-6.86 %) |